authors.elsevier.com/a/1gj2y14kplv9…

Excited to open phase 3 #clinicaltrial of #Stereotactic #Radiotherapy for #Oligometastatic #RenalCarcinoma (EA8211-SOAR), comparing systemic therapy vs. SAbR for mRCC patients w/ endpoints of OS & ≥Gr3 AE. ECOG-ACRIN Cancer Research Group NRG Oncology ASTRO KidneyCancerProgram UTSW Simmons Cancer Center tinyurl.com/yc8rrr7z

🧵4/ Median F/U=43months. 100% local control + cancer specific survival throughout the lifetime of the trial – i.e. no patient failed or died of cancer. Renal function decline similar to partial nephrectomy; baseline eGFR=60mls/min, ⬇️14.6mls/min post SABR. #ASTRO23 Kidney Cancer

Our department is seeking a clinical radiation oncologist for our genitourinary disease-oriented team! Learn more and apply in the link below! 🔽🔽🔽 jobs.utsouthwestern.edu/job/17591322/c…

Our department is recruiting a senior laboratory research Ph.D. scientist or M.D./Ph.D. physician-scientist to lead and substantially build our Radiation and Molecular Oncology section. Learn more and apply here: bit.ly/3TgNEpd